Literature DB >> 30145792

Melatonin, a calpain inhibitor in the central nervous system: Current status and future perspectives.

Omid Reza Tamtaji1, Naghmeh Mirhosseini2, Russel J Reiter3, Abolfazl Azami4, Zatollah Asemi5.   

Abstract

Dysregulation of neuronal Ca2+ and oxidative stress plays an important role in the activation of cysteine proteases including calpains and caspases that contribute to neuronal death. In neurodegenerative diseases, traumatic brain injury, stroke, and neuropathic pain calpain activities are markedly increased. Melatonin is a beneficial supplement in the treatment of central nervous system (CNS) disorders. Melatonin is a potent antioxidant and works as a free-radical scavenger to regulate a large number of molecular pathways, including oxidative stress, inflammation, apoptosis, and cell death under different pathological conditions. However, limited studies have evaluated the inhibitory effect of melatonin on calpains. This review summarizes the current knowledge related to the effects of melatonin on calpains in some of the common CNS disorders.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  calpain; central nervous system; melatonin

Year:  2018        PMID: 30145792     DOI: 10.1002/jcp.27084

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  3 in total

Review 1.  Can Berberine Serve as a New Therapy for Parkinson's Disease?

Authors:  Ehsan Dadgostar; Mahsa Moghanlou; Mehrnoosh Parvaresh; Salimeh Mohammadi; Mohammadali Khandan; Michael Aschner; Hamed Mirzaei; Omid Reza Tamtaji
Journal:  Neurotox Res       Date:  2022-06-06       Impact factor: 3.978

Review 2.  Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms.

Authors:  Omid Reza Tamtaji; Russel J Reiter; Reza Alipoor; Ehsan Dadgostar; Ebrahim Kouchaki; Zatollah Asemi
Journal:  Cell Mol Neurobiol       Date:  2019-08-06       Impact factor: 5.046

Review 3.  Effects of functionally diverse calpain system on immune cells.

Authors:  Yueqi Chen; Zhaoliang Su; Fang Liu
Journal:  Immunol Res       Date:  2021-01-23       Impact factor: 2.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.